down arrow

Jin Medical International Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG5140V1041
USD
0.21
0 (0.29%)

Dec 19

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

0.180.22

52 Week

0.181.42
Valuation
Technical
Day's Volume

CASH

141.14 k

Shareholding (Sep 2024)

FII

0.20%

Held by 6 FIIs

DII

98.73%

Held by 1 DIIs

Promoter

0.00%

How big is Jin Medical International Ltd.?

22-Jun-2025

As of Jun 18, Jin Medical International Ltd. has a market capitalization of 108.02 million, with net sales of 0.48 million and a net profit of -15.95 million over the latest four quarters. Shareholder's funds are 28.82 million, and total assets are 45.80 million as of Sep 24.

As of Jun 18, Jin Medical International Ltd. has a market capitalization of 108.02 million, classifying it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of net sales for the latest four quarters is 0.48 million, while the sum of net profit for the same period is -15.95 million.<BR><BR>As of Sep 24, the shareholder's funds amount to 28.82 million, and total assets are reported at 45.80 million.

Read More

What does Jin Medical International Ltd. do?

22-Jun-2025

Jin Medical International Ltd. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $0 million and a net profit loss of $1 million as of September 2013. It has a market cap of $108.02 million and key metrics indicating significant financial challenges.

Overview:<BR>Jin Medical International Ltd. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 0 Million (Quarterly Results - Sep 2013) <BR>Most recent Net Profit: -1 Million (Quarterly Results - Sep 2013) <BR>Market cap: USD 108.02 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.54 <BR>Return on Equity: -999,999.00% <BR>Price to Book: 3.75 <BR><BR>Contact Details:<BR>Registrar Address: Not available.

Read More

Is Jin Medical International Ltd. technically bullish or bearish?

20-Sep-2025

As of August 22, 2025, Jin Medical International Ltd. shows a mildly bearish trend with mixed technical indicators, underperforming the S&P 500 significantly year-to-date and over the past year.

As of 22 August 2025, the technical trend for Jin Medical International Ltd. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD shows no signal. The RSI is bullish on the monthly timeframe but shows no signal weekly. Moving averages are bearish on the daily timeframe, and the Bollinger Bands are bearish weekly but sideways monthly. The Dow Theory indicates a mildly bearish trend on the weekly chart with no trend on the monthly.<BR><BR>In terms of performance, Jin Medical has significantly underperformed the S&P 500 across multiple periods, with a year-to-date return of -26.75% compared to the S&P 500's 12.22%, and a one-year return of -77.73% against the S&P 500's 17.14%. Overall, the current technical stance is mildly bearish, driven primarily by the bearish daily moving averages and mixed signals from the MACD and RSI.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 99 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.54

stock-summary
Return on Equity

-999,999.00%

stock-summary
Price to Book

3.42

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Sep 2013)
Net Profit:
-1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-63.32%
0%
-63.32%
6 Months
-70.34%
0%
-70.34%
1 Year
-75.43%
0%
-75.43%
2 Years
-96.33%
0%
-96.33%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Jin Medical International Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
8.16%
EBIT Growth (5y)
-241.64%
EBIT to Interest (avg)
-10.38
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.54
Sales to Capital Employed (avg)
0.02
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
1.88%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.18
EV to EBIT
-15.37
EV to EBITDA
-16.16
EV to Capital Employed
7.88
EV to Sales
105.01
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-51.26%
ROE (Latest)
-55.37%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Dow Theory
Bearish
Bearish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 4 Schemes (1.06%)

Foreign Institutions

Held by 6 Foreign Institutions (0.2%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'13 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2013 is -100.00% vs 0.00% in Sep 2012",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2013 is 84.15% vs -485.71% in Sep 2012",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'13",
        "Sep'12",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "-0.00",
          "val2": "0.40",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.30",
          "val2": "-4.70",
          "chgp": "72.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.20",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.30",
          "val2": "-8.20",
          "chgp": "84.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Sep'22",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Sep 2022 is -7.69% vs 28.40% in Sep 2021",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Sep 2022 is 3.85% vs 18.18% in Sep 2021",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'22",
        "Sep'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "19.20",
          "val2": "20.80",
          "chgp": "-7.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.50",
          "val2": "3.00",
          "chgp": "-16.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2.70",
          "val2": "2.60",
          "chgp": "3.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "111.00%",
          "val2": "126.70%",
          "chgp": "-1.57%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Sep'13 - YoYstock-summary
Sep'13
Sep'12
Change(%)
Net Sales
-0.00
0.40
-100.00%
Operating Profit (PBDIT) excl Other Income
-1.30
-4.70
72.34%
Interest
0.10
0.20
-50.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.30
-8.20
84.15%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2013 is -100.00% vs 0.00% in Sep 2012

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Sep 2013 is 84.15% vs -485.71% in Sep 2012

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Sep'22stock-summary
Sep'22
Sep'21
Change(%)
Net Sales
19.20
20.80
-7.69%
Operating Profit (PBDIT) excl Other Income
2.50
3.00
-16.67%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
2.70
2.60
3.85%
Operating Profit Margin (Excl OI)
111.00%
126.70%
-1.57%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Sep 2022 is -7.69% vs 28.40% in Sep 2021

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Sep 2022 is 3.85% vs 18.18% in Sep 2021

All Annual Resultsstock-summary
stock-summaryCompany CV
About Jin Medical International Ltd. stock-summary
stock-summary
Jin Medical International Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."